Accelerated cancer drug approvals yield modest survival gains at significant Medicare cost
byHarvard Pilgrim Health Care InstituteCredit: Unsplash/CC0 Public DomainEarly access to new cancer drugs, granted accelerated approval by the U.S. Food and Drug Administration (FDA), has provided mix
Updated on: January 07,2026
Accelerated cancer drug approvals yield modest survival gains at significant Medicare cost
byHarvard Pilgrim Health Care InstituteCredit: Unsplash/CC0 Public DomainEarly access to new cancer drugs, granted accelerated approval by the U.S. Food and Drug Administration (FDA), has provided mix
Updated on:January 07,2026
